Literature DB >> 8932256

Amplification of natural regulatory immune mechanisms for transplantation tolerance.

Z K Chen1, S P Cobbold, H Waldmann, S Metcalfe.   

Abstract

There is a need to derive donor-specific tolerance in clinical organ transplantation, where potential benefits remain overshadowed by chronic rejection and side effects of continual immunosuppressive therapy. It is known that the mature immune system in mice can be reprogrammed to accept a foreign graft as if it were "self." Here we show that, once generated, this state of operational tolerance becomes self-sustaining, imposing itself on new cohorts of lymphocytes as they arise. These new cohorts retain specificity for the tolerizing antigen and can be selectively amplified to tolerate new antigens that have linked expression with the original tolerogen. Regulation is critically dependent upon the continuous presence of tolerizing antigen and is mediated by the CD4+ lymphocyte population. We propose that such natural mechanisms of immune regulation may eventually be exploited for transplantation tolerance, even in fully immune-competent recipients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8932256     DOI: 10.1097/00007890-199611150-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  25 in total

Review 1.  Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Authors:  K Honey; S P Cobbold; H Waldmann
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Proposed mechanisms of transfusion-induced immunomodulation.

Authors:  S A Kirkley
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

3.  Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell-dependent mechanism.

Authors:  Kenneth K Wong; Matthew J Carpenter; Lesley L Young; Susan J Walker; Grahame McKenzie; Alyson J Rust; George Ward; Laura Packwood; Karen Wahl; Luc Delriviere; Gerard Hoyne; Paul Gibbs; Brian R Champion; Jonathan R Lamb; Margaret J Dallman
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 4.  The peripheral generation of CD4+ CD25+ regulatory T cells.

Authors:  Arne N Akbar; Leonie S Taams; Mike Salmon; Milica Vukmanovic-Stejic
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

Review 5.  Tregs and transplantation tolerance.

Authors:  Patrick T Walsh; Devon K Taylor; Laurence A Turka
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

6.  Regulation and privilege in transplantation tolerance.

Authors:  Herman Waldmann; Elizabeth Adams; Paul Fairchild; Stephen Cobbold
Journal:  J Clin Immunol       Date:  2008-09-06       Impact factor: 8.317

Review 7.  Axotrophin and leukaemia inhibitory factor (LIF) in transplantation tolerance.

Authors:  Su M Metcalfe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

8.  Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients.

Authors:  Giorgio Raimondi; Tina L Sumpter; Benjamin M Matta; Mahesh Pillai; Natasha Corbitt; Yoram Vodovotz; Zhiliang Wang; Angus W Thomson
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

9.  CD40-ligand in primate cardiac allograft and viral immunity.

Authors:  R N Pierson; J E Crowe; S Pfeiffer; J Atkinson; A Azimzadeh; G G Miller
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

10.  In primed allo-tolerance, TIM-3-Ig rapidly suppresses TGFbeta, but has no immediate effect on Foxp3.

Authors:  Poorni A D S Muthukumarana; Xin X Zheng; Bruce R Rosengard; Terry B Strom; Susan M Metcalfe
Journal:  Transpl Int       Date:  2008-02-16       Impact factor: 3.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.